NMPA Approval

Doxorubicin Hydrochloride Liposome Injection

Approval Number

国药准字H20234166

Company浙江圣兆药物科技股份有限公司

Registration Date

September 12, 2023

Drug Information

Generic Name

盐酸多柔比星脂质体注射液

Dosage Form

注射剂

Strength

10ml:20mg

Drug Type

化学药品

Registration Date

September 12, 2023

Company Information

Applicant Company

Company Name浙江圣兆药物科技股份有限公司

Company Address

浙江省杭州市临平区东湖街道超峰西路6号2幢808室

Manufacturing Company

Company Name浙江海正药业股份有限公司

Company Address

浙江省杭州市富阳区胥口镇海正路10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸多柔比星脂质体注射液 - NMPA 批准文号 | MedPath